Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus
- Autores
- Frecha, Cecilia Ariana; Chevalier, Sébastien A.; van Uden, Patrick; Rubio, Ivonne; Siouda, Maha; Saidj, Djamel; Cohen, Camille; Lomonte, Patrick; Accardi, Rosita; Tommasino, Massimo
- Año de publicación
- 2015
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- EVER1 and EVER2 are mutated in epidermodysplasia verruciformis patients, who are susceptible to human betapapillomavirus (HPV) infection. It is unknown whether their products control the infection of other viruses. Here, we show that the expression of both genes in B cells is activated immediately after Epstein-Barr virus (EBV) infection, whereas at later stages, it is strongly repressed via activation of the NF-κB signaling pathway by latent membrane protein 1 (LMP1). Ectopic expression of EVER1 impairs the ability of EBV to infect B cells.
Fil: Frecha, Cecilia Ariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; Argentina. International Agency For Research On Cancer; Francia
Fil: Chevalier, Sébastien A.. International Agency For Research On Cancer; Francia
Fil: van Uden, Patrick. International Agency For Research On Cancer; Francia
Fil: Rubio, Ivonne. International Agency For Research On Cancer; Francia
Fil: Siouda, Maha. International Agency For Research On Cancer; Francia
Fil: Saidj, Djamel. International Agency For Research On Cancer; Francia
Fil: Cohen, Camille. Université Claude Bernard Lyon 1; Francia. Centre National de la Recherche Scientifique; Francia
Fil: Lomonte, Patrick. Centre National de la Recherche Scientifique; Francia. Université Claude Bernard Lyon 1; Francia
Fil: Accardi, Rosita. International Agency For Research On Cancer; Francia
Fil: Tommasino, Massimo. International Agency For Research On Cancer; Francia - Materia
-
EVER1
EVER2
EBV-LMP1
BCELLS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/99773
Ver los metadatos del registro completo
id |
CONICETDig_5604530c8a22e4f3715c3a8175069930 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/99773 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virusFrecha, Cecilia ArianaChevalier, Sébastien A.van Uden, PatrickRubio, IvonneSiouda, MahaSaidj, DjamelCohen, CamilleLomonte, PatrickAccardi, RositaTommasino, MassimoEVER1EVER2EBV-LMP1BCELLShttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1EVER1 and EVER2 are mutated in epidermodysplasia verruciformis patients, who are susceptible to human betapapillomavirus (HPV) infection. It is unknown whether their products control the infection of other viruses. Here, we show that the expression of both genes in B cells is activated immediately after Epstein-Barr virus (EBV) infection, whereas at later stages, it is strongly repressed via activation of the NF-κB signaling pathway by latent membrane protein 1 (LMP1). Ectopic expression of EVER1 impairs the ability of EBV to infect B cells.Fil: Frecha, Cecilia Ariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; Argentina. International Agency For Research On Cancer; FranciaFil: Chevalier, Sébastien A.. International Agency For Research On Cancer; FranciaFil: van Uden, Patrick. International Agency For Research On Cancer; FranciaFil: Rubio, Ivonne. International Agency For Research On Cancer; FranciaFil: Siouda, Maha. International Agency For Research On Cancer; FranciaFil: Saidj, Djamel. International Agency For Research On Cancer; FranciaFil: Cohen, Camille. Université Claude Bernard Lyon 1; Francia. Centre National de la Recherche Scientifique; FranciaFil: Lomonte, Patrick. Centre National de la Recherche Scientifique; Francia. Université Claude Bernard Lyon 1; FranciaFil: Accardi, Rosita. International Agency For Research On Cancer; FranciaFil: Tommasino, Massimo. International Agency For Research On Cancer; FranciaAmerican Society for Microbiology2015-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/99773Frecha, Cecilia Ariana; Chevalier, Sébastien A.; van Uden, Patrick; Rubio, Ivonne; Siouda, Maha; et al.; Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus; American Society for Microbiology; Journal of Virology; 89; 2; 1-2015; 1461-14670022-538XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://jvi.asm.org/content/89/2/1461info:eu-repo/semantics/altIdentifier/doi/10.1128/JVI.02936-14info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:00:31Zoai:ri.conicet.gov.ar:11336/99773instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:00:31.322CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus |
title |
Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus |
spellingShingle |
Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus Frecha, Cecilia Ariana EVER1 EVER2 EBV-LMP1 BCELLS |
title_short |
Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus |
title_full |
Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus |
title_fullStr |
Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus |
title_full_unstemmed |
Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus |
title_sort |
Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus |
dc.creator.none.fl_str_mv |
Frecha, Cecilia Ariana Chevalier, Sébastien A. van Uden, Patrick Rubio, Ivonne Siouda, Maha Saidj, Djamel Cohen, Camille Lomonte, Patrick Accardi, Rosita Tommasino, Massimo |
author |
Frecha, Cecilia Ariana |
author_facet |
Frecha, Cecilia Ariana Chevalier, Sébastien A. van Uden, Patrick Rubio, Ivonne Siouda, Maha Saidj, Djamel Cohen, Camille Lomonte, Patrick Accardi, Rosita Tommasino, Massimo |
author_role |
author |
author2 |
Chevalier, Sébastien A. van Uden, Patrick Rubio, Ivonne Siouda, Maha Saidj, Djamel Cohen, Camille Lomonte, Patrick Accardi, Rosita Tommasino, Massimo |
author2_role |
author author author author author author author author author |
dc.subject.none.fl_str_mv |
EVER1 EVER2 EBV-LMP1 BCELLS |
topic |
EVER1 EVER2 EBV-LMP1 BCELLS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
EVER1 and EVER2 are mutated in epidermodysplasia verruciformis patients, who are susceptible to human betapapillomavirus (HPV) infection. It is unknown whether their products control the infection of other viruses. Here, we show that the expression of both genes in B cells is activated immediately after Epstein-Barr virus (EBV) infection, whereas at later stages, it is strongly repressed via activation of the NF-κB signaling pathway by latent membrane protein 1 (LMP1). Ectopic expression of EVER1 impairs the ability of EBV to infect B cells. Fil: Frecha, Cecilia Ariana. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Biología Celular y Neurociencia "Prof. Eduardo de Robertis". Universidad de Buenos Aires. Facultad de Medicina. Instituto de Biología Celular y Neurociencia; Argentina. International Agency For Research On Cancer; Francia Fil: Chevalier, Sébastien A.. International Agency For Research On Cancer; Francia Fil: van Uden, Patrick. International Agency For Research On Cancer; Francia Fil: Rubio, Ivonne. International Agency For Research On Cancer; Francia Fil: Siouda, Maha. International Agency For Research On Cancer; Francia Fil: Saidj, Djamel. International Agency For Research On Cancer; Francia Fil: Cohen, Camille. Université Claude Bernard Lyon 1; Francia. Centre National de la Recherche Scientifique; Francia Fil: Lomonte, Patrick. Centre National de la Recherche Scientifique; Francia. Université Claude Bernard Lyon 1; Francia Fil: Accardi, Rosita. International Agency For Research On Cancer; Francia Fil: Tommasino, Massimo. International Agency For Research On Cancer; Francia |
description |
EVER1 and EVER2 are mutated in epidermodysplasia verruciformis patients, who are susceptible to human betapapillomavirus (HPV) infection. It is unknown whether their products control the infection of other viruses. Here, we show that the expression of both genes in B cells is activated immediately after Epstein-Barr virus (EBV) infection, whereas at later stages, it is strongly repressed via activation of the NF-κB signaling pathway by latent membrane protein 1 (LMP1). Ectopic expression of EVER1 impairs the ability of EBV to infect B cells. |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/99773 Frecha, Cecilia Ariana; Chevalier, Sébastien A.; van Uden, Patrick; Rubio, Ivonne; Siouda, Maha; et al.; Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus; American Society for Microbiology; Journal of Virology; 89; 2; 1-2015; 1461-1467 0022-538X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/99773 |
identifier_str_mv |
Frecha, Cecilia Ariana; Chevalier, Sébastien A.; van Uden, Patrick; Rubio, Ivonne; Siouda, Maha; et al.; Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus; American Society for Microbiology; Journal of Virology; 89; 2; 1-2015; 1461-1467 0022-538X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://jvi.asm.org/content/89/2/1461 info:eu-repo/semantics/altIdentifier/doi/10.1128/JVI.02936-14 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Society for Microbiology |
publisher.none.fl_str_mv |
American Society for Microbiology |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269642584752128 |
score |
13.13397 |